Cancer

Transmission Electron Microscope Market to Grow by USD 528.8 Million (2024-2028), Driven by Nanotechnology Focus, AI-Powered Market Evolution Report – Technavio

NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global transmission electron microscope market…

1 year ago

Million Mammogram Challenge Launches with OUTFRONT Media in New York City in Partnership with MaleRoom Founder Mindie Kaplan and Imerman Angels

New 360-Degree Campaign Launches October 1 for Breast Cancer Awareness Month, Inviting Women to Share and Post Mammogram Dates to…

1 year ago

BLACKDOCTOR.ORG ANNOUNCES AI FEATURE FOR CULTURALLY RELEVANT CONTENT

BDO Issues Call-to-Action to Black Women to ask: "How do I get my doctor to listen to me?" CHICAGO, Oct.…

1 year ago

G-SHOCK Announces New Pink Ribbon Models in Partnership with Breast Cancer Research Foundation

Introducing the Exclusive DW5600PK-1 and GMDS5610PK-4, Designed to Raise Awareness and Support for Breast Cancer Awareness Month   DOVER, N.J.,…

1 year ago

Florida Cancer Specialists & Research Institute Welcomes Board-certified Medical Oncologist and Hematologist Yasir Khan, MD to Lee County

FORT MYERS, Fla., Oct. 1, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome board-certified medical…

1 year ago

Helix and WakeMed to Launch Major Genetic Health Initiative in Wake County

4-year population health program to improve preventive care and provide greater precision care SAN MATEO, Calif., and RALEIGH, N.C., Oct. 1,…

1 year ago

Breakthrough Women in Science & Medicine series addresses breast cancer and dense breast tissue with Dr. Rachel Brem

SCHAUMBURG, Ill., Oct. 1, 2024 /PRNewswire/ --The Breakthrough Women in Science & Medicine series is proud to announce that Dr.…

1 year ago

Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT’s 2024 Advancing Gene + Cell Therapies for Cancer Conference

Marlborough, Massachusetts--(Newsfile Corp. - October 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary…

1 year ago

Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer

Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of…

1 year ago